Cargando…

Evolution of Drug Interactions With Antiretroviral Medication in People With HIV

BACKGROUND: Polypharmacy and drug interactions are important issues for HIV-infected individuals. The number and nature of those interactions are continuously evolving with the use of new antiretroviral drugs and the aging of HIV-infected individuals. We aimed to analyze this evolution over time. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Moussaoui, Majdouline, Lambert, Iseult, Maes, Nathalie, Sauvage, Anne-Sophie, Frippiat, Frédéric, Meuris, Christelle, Uurlings, Françoise, Lecomte, Marianne, Léonard, Philippe, Fombellida, Karine, Vaira, Dolores, Vercheval, Christelle, Moutschen, Michel, Darcis, Gilles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7651038/ https://www.ncbi.nlm.nih.gov/pubmed/33204748 http://dx.doi.org/10.1093/ofid/ofaa416

Ejemplares similares

Factors associated with late presentation for HIV care in a single Belgian reference center: 2006–2017
por: Darcis, Gilles, et al.
Publicado: (2018)

Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV
por: Plum, Pierre-Emmanuel, et al.
Publicado: (2021)

Human Immunodeficiency Virus Viral Load Monitoring and Rate of Virologic Suppression Among Patients Receiving Antiretroviral Therapy in Democratic Republic of the Congo, 2013–2020
por: Mayasi Ngongo, Nadine, et al.
Publicado: (2023)

Impact of coronavirus pandemic and containment measures on HIV diagnosis
por: Darcis, Gilles, et al.
Publicado: (2020)

Meropenem: continuous or extended infusion?
por: Frippiat, Frédéric, et al.
Publicado: (2020)

Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections
por: Desmecht, Salomé, et al.
Publicado: (2022)

Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium
por: Meuris, Christelle, et al.
Publicado: (2021)

Virus-Specific T-Cell Therapy for Viral Infections of the Central Nervous System: A Review
por: Lambert, Nicolas, et al.
Publicado: (2023)

Evaluation of Screening Program and Phylogenetic Analysis of SARS-CoV-2 Infections among Hospital Healthcare Workers in Liège, Belgium
por: El Moussaoui, Majdouline, et al.
Publicado: (2022)

Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV
por: El Moussaoui, Majdouline, et al.
Publicado: (2023)

Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIV
por: Moussaoui, Majdouline El, et al.
Publicado: (2022)

The Dynamic Relationship between the Intention and Final Decision for the COVID-19 Booster: A Study among Students and Staff at the University of Liège, Belgium
por: Paridans, Marine, et al.
Publicado: (2022)

Retention in care and predictors of attrition among HIV-infected patients who started antiretroviral therapy in Kinshasa, DRC, before and after the implementation of the ‘treat-all’ strategy
por: Mayasi, Nadine, et al.
Publicado: (2022)

Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium
por: De Voeght, Adrien, et al.
Publicado: (2017)

Controlling SARS-CoV-2 in schools using repetitive testing strategies
por: Torneri, Andrea, et al.
Publicado: (2022)

Downregulation of CD94/NKG2A inhibitory receptors on CD8(+ )T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts
por: Zeddou, Mustapha, et al.
Publicado: (2007)

Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017
por: Ngongo, Nadine Mayasi, et al.
Publicado: (2021)

Factors Associated With Liver Steatosis in People With Human Immunodeficiency Virus on Contemporary Antiretroviral Therapy
por: Riebensahm, Carlotta, et al.
Publicado: (2022)

Prevalence and Evolution of Transmitted Human Immunodeficiency Virus Drug Resistance in Belgium Between 2013 and 2019
por: Mortier, Virginie, et al.
Publicado: (2022)

Antiretroviral Therapy as Prevention of … Pneumococcal Infections?
por: Lesourd, Anaïs, et al.
Publicado: (2016)

The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment
por: Kamal, Susan, et al.
Publicado: (2017)

Plasma Profiles of Inflammatory Markers Associated With Active Tuberculosis in Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Positive Individuals
por: Olsson, Oskar, et al.
Publicado: (2019)

Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy
por: Surial, Bernard, et al.
Publicado: (2023)

Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
por: Martinello, Marianne, et al.
Publicado: (2016)

Increased Regulatory T-Cell Percentage Contributes to Poor CD4(+) Lymphocytes Recovery: A 2-Year Prospective Study After Introduction of Antiretroviral Therapy
por: Saison, Julien, et al.
Publicado: (2015)

Association of First-Line and Second-Line Antiretroviral Therapy Adherence
por: Ramadhani, Habib O., et al.
Publicado: (2014)

Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial
por: Baker, Jason V., et al.
Publicado: (2016)

Reconstruction of SARS-CoV-2 outbreaks in a primary school using epidemiological and genomic data
por: Kremer, Cécile, et al.
Publicado: (2023)

Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy
por: Darcis, Gilles, et al.
Publicado: (2017)

Prevalence and Outcomes of Hepatitis B Coinfection and Associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a Rural Tanzanian Human Immunodeficiency Virus Cohort
por: Ramírez-Mena, Adrià, et al.
Publicado: (2016)

Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
por: Meloni, Seema T, et al.
Publicado: (2017)

Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status
por: Gowda, Charitha, et al.
Publicado: (2017)

Cesarean scar pregnancie
por: Boujoual, Majdouline, et al.
Publicado: (2018)

Transcriptional Changes in CD8(+) T Cells During Antiretroviral Therapy Intensified With Raltegravir
por: Ouyang, Zhengyu, et al.
Publicado: (2015)

Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy
por: Bhagwat, Priya, et al.
Publicado: (2019)

Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens
por: Rhee, Soo-Yon, et al.
Publicado: (2020)

Antiretroviral Refill Histories as a Predictor of Future Human Immunodeficiency Virus Viremia
por: Sokpa, Darryl, et al.
Publicado: (2022)

Observational Study Evaluating the Seroprotection of HepB-alum Vaccine and HepB-CpG Vaccine in People With HIV
por: Reilly-Evans, Brenna, et al.
Publicado: (2023)

Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study
por: Darcis, Gilles, et al.
Publicado: (2021)

1983. Oral Therapy with Rifampin Associated with Minocycline or Moxifloxacin in Vertebral Osteomyelitis due to Gram-Positive Micro-organisms: A Retrospective Study of 64 Cases
por: Gaspard, Laura, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_72d8clev4btonrlb3gug64pc75